Product image of Nevirapine Milpharm (Nevirapine) supplied by GNH India

Nevirapine Milpharm

Active Ingredient:
Nevirapine
Origin:
EU

Nevirapine Milpharm (Nevirapine)

Nevirapine, the active ingredient in Nevirapine Milpharm, is a non‑nucleoside reverse transcriptase inhibitor (NNRTI) presented as an oral tablet for oral administration. It inhibits HIV‑1 replication by targeting the reverse transcriptase enzyme and is indicated for use in adults and adolescents living with HIV‑1 infection.

GNH India supplies Nevirapine Milpharm as a licensed, GDP‑compliant product sourced from the European Union, providing reliable access to hospitals, pharmacies and clinics worldwide. The company follows strict quality standards and supports international procurement processes.

Manufacturer / TM Owner

Milpharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nevirapine is used in antiretroviral therapy to suppress HIV‑1 replication. It is part of combination regimens for the following conditions:

  • HIV‑1 infection (treatment‑naïve adults): reduces viral load and improves immune function.
  • HIV‑1 infection (treatment‑experienced adults): restores virologic control when resistance develops to other agents.
  • HIV‑1 infection (adolescents): provides effective viral suppression as part of pediatric ART protocols.

How It Works

  • Nevirapine binds to a hydrophobic pocket of the HIV‑1 reverse transcriptase enzyme at a site distinct from the nucleoside binding region. This allosteric interaction impedes the enzyme’s RNA‑dependent DNA polymerase activity, preventing conversion of viral RNA into DNA and thereby halting viral replication within infected cells.

Side Effects

Nevirapine may cause a range of adverse reactions. Patients should be monitored for both common and serious events.

Common Side Effects

  • Rash: mild skin eruption that may be itchy.
  • Nausea: feeling of stomach upset, sometimes with vomiting.
  • Fatigue: generalized tiredness affecting daily activities.
  • Headache: mild to moderate pain in the head region.

Serious or Rare Side Effects

  • Stevens‑Johnson syndrome: severe skin reaction with blistering and detachment.
  • Hepatic toxicity: elevated liver enzymes, hepatitis, or liver failure.
  • Severe hypersensitivity: fever, eosinophilia, and systemic symptoms requiring immediate discontinuation.

Precautions & Warnings

Nevirapine therapy requires careful monitoring and patient education.

  • Liver monitoring: perform baseline and periodic liver function tests.
  • Hepatitis B screening: test before initiating therapy to assess risk.
  • Hypersensitivity history: discontinue immediately if rash or systemic allergic reaction occurs.
  • Drug interactions: avoid co‑administration with strong CYP3A inducers.
  • Pregnancy and breastfeeding: assess risk–benefit; use only when clearly needed.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Avoid Interactions

Nevirapine interacts with several medicines; clinicians should review patient regimens.

Major Interactions (Avoid)

  • Rifampicin: markedly reduces nevirapine plasma levels.
  • St. John’s wort: induces metabolism leading to subtherapeutic exposure.
  • Carbamazepine: strong CYP3A inducer that lowers nevirapine concentrations.

Moderate Interactions (Monitor Closely)

  • Efavirenz: may increase hepatotoxicity risk.
  • Zidovudine: combined use can enhance hematologic toxicity.
  • Methadone: nevirapine may reduce methadone levels, requiring dose adjustment.

Frequently Asked Questions

Nevirapine Milpharm contains the antiretroviral agent nevirapine, which is used as part of combination therapy to treat HIV‑1 infection in adults and adolescents. It helps lower the amount of virus in the body and supports immune system recovery.

Nevirapine binds to a specific pocket on the HIV‑1 reverse transcriptase enzyme, preventing the enzyme from converting viral RNA into DNA. This blocks a critical step in the viral replication cycle, reducing the spread of the virus within the body.

The prescribed dose of Nevirapine Milpharm is determined by the treating physician based on the patient’s clinical condition, weight, and other medications. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety in pregnancy and lactation must be evaluated by a healthcare professional. Nevirapine may be used when the benefits outweigh potential risks, but clinicians should monitor both mother and infant closely for any adverse effects.

Enquiries can be submitted on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Nevirapine belongs to the non‑nucleoside reverse transcriptase inhibitor (NNRTI) class, which differs from nucleoside reverse transcriptase inhibitors (NRTIs) and protease inhibitors. NNRTIs bind directly to reverse transcriptase, offering a distinct resistance profile and often fewer pill burdens in combination regimens.

Nevirapine Milpharm should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

Nevirapine Milpharm is taken orally, usually with food to reduce gastrointestinal discomfort. The tablet should be swallowed whole with a full glass of water, and dosing times are typically spaced to maintain consistent blood levels as directed by the prescriber.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, hepatic toxicity that can lead to hepatitis or liver failure, and systemic hypersensitivity reactions. Patients should seek immediate medical attention if they develop rash, jaundice, fever, or other concerning symptoms.

Nevirapine Milpharm is contraindicated in individuals with a known hypersensitivity to nevirapine or any component of the formulation, and in patients with severe hepatic impairment. Caution is also advised for those with a history of severe skin reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nevirapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT